Clinical trial
Apathy in Dementia Methylphenidate Trial 2
NCT02346201 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apathy in Dementia Methylphenidate Trial 2
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- July 15, 2020
- Enrollment
- 200 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, apathy